We have synthesized novel glutathione (GSH) responsive silica nanoparticles by introducing disulfide bonds into silica nanoparticles, which are highly uniform in size and show excellent blood compatibility. The subsequent degradation process under physiological conditions shows their promising potential for medical treatment and diagnosis.